A clinical study for evaluating the safety of excessive intake of salmon nasal cartilage extract including proteoglycan

A clinical study for evaluating the safety of excessive intake of salmon nasal cartilage extract including proteoglycan - A clinical study for evaluating the safety of excessive intake of salmon nasal cartilage extract

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027732

Enrollment

Registered

2017-06-13

Start date

2015-07-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Consumption of salmon nasal cartilage extract, 5 fold quantity of recommended daily intake, for 4 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Healthy men and women. 2) Subjects giving written informed consent based on Declaration of Helsinki. 3) Subjects who can intake test food sample every day during test period. 4) Subjects who can attend to every examinations.

Exclusion criteria

Exclusion criteria: 1) Subjects who take drugs or supplements 2) Subjects undergoing treatment for some serious disorders 3) Subjects who make a blood donation within the last month before and during the test 4) Women who are pregnant or breast-feeding 5) Subjects who have allergies to salmon, shrimp or crab 6) Subjects whose participation is deemed inappropriate by pilot questionnaire, clinical test values or physical exam values 7) Subjects who cannot follow a guideline of test 8) Subjects undergoing hormone replacement therapy 9) Subjects whose participation is deemed inappropriate by a test director

Design outcomes

Primary

Measure	Time frame
Hematologic test Biochemistry test Urinalysis Medical interview Adverse event	—

Countries

Japan

Contacts

Public ContactKazunori Enya

Ichimaru Pharcos Co., Ltd. Product Development

enya-kazunori@ichimaru.co.jp058-320-1037

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026